Logo image of CZR

CAESARS ENTERTAINMENT INC (CZR) Stock Fundamental Analysis

NASDAQ:CZR - US12769G1004 - Common Stock

26.75 USD
+1.75 (+7%)
Last: 8/22/2025, 8:01:25 PM
26.77 USD
+0.02 (+0.07%)
After Hours: 8/22/2025, 8:01:25 PM
Fundamental Rating

2

CZR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 131 industry peers in the Hotels, Restaurants & Leisure industry. CZR may be in some trouble as it scores bad on both profitability and health. CZR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CZR has reported negative net income.
In the past year CZR had a positive cash flow from operations.
In the past 5 years CZR reported 4 times negative net income.
Of the past 5 years CZR 4 years had a positive operating cash flow.
CZR Yearly Net Income VS EBIT VS OCF VS FCFCZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

CZR's Return On Assets of -0.60% is on the low side compared to the rest of the industry. CZR is outperformed by 67.94% of its industry peers.
CZR's Return On Equity of -5.01% is in line compared to the rest of the industry. CZR outperforms 45.80% of its industry peers.
CZR has a Return On Invested Capital (5.76%) which is comparable to the rest of the industry.
CZR had an Average Return On Invested Capital over the past 3 years of 5.76%. This is significantly below the industry average of 15.87%.
The last Return On Invested Capital (5.76%) for CZR is above the 3 year average (5.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.6%
ROE -5.01%
ROIC 5.76%
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
CZR Yearly ROA, ROE, ROICCZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CZR has a better Operating Margin (19.32%) than 77.86% of its industry peers.
In the last couple of years the Operating Margin of CZR has grown nicely.
The Gross Margin of CZR (48.39%) is comparable to the rest of the industry.
CZR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.32%
PM (TTM) N/A
GM 48.39%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
CZR Yearly Profit, Operating, Gross MarginsCZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CZR is still creating some value.
The number of shares outstanding for CZR has been reduced compared to 1 year ago.
CZR has more shares outstanding than it did 5 years ago.
CZR has a worse debt/assets ratio than last year.
CZR Yearly Shares OutstandingCZR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CZR Yearly Total Debt VS Total AssetsCZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CZR has an Altman-Z score of 0.55. This is a bad value and indicates that CZR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CZR (0.55) is worse than 76.34% of its industry peers.
CZR has a debt to FCF ratio of 503.20. This is a negative value and a sign of low solvency as CZR would need 503.20 years to pay back of all of its debts.
CZR has a worse Debt to FCF ratio (503.20) than 61.83% of its industry peers.
A Debt/Equity ratio of 6.43 is on the high side and indicates that CZR has dependencies on debt financing.
The Debt to Equity ratio of CZR (6.43) is worse than 63.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.43
Debt/FCF 503.2
Altman-Z 0.55
ROIC/WACC1.03
WACC5.6%
CZR Yearly LT Debt VS Equity VS FCFCZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.82 indicates that CZR may have some problems paying its short term obligations.
CZR has a Current ratio (0.82) which is comparable to the rest of the industry.
CZR has a Quick Ratio of 0.82. This is a bad value and indicates that CZR is not financially healthy enough and could expect problems in meeting its short term obligations.
CZR's Quick ratio of 0.81 is in line compared to the rest of the industry. CZR outperforms 47.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.81
CZR Yearly Current Assets VS Current LiabilitesCZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

CZR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.67%.
CZR shows a decrease in Revenue. In the last year, the revenue decreased by -0.15%.
CZR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.78% yearly.
EPS 1Y (TTM)-22.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1850%
Revenue 1Y (TTM)-0.15%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%2.72%

3.2 Future

CZR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.24% yearly.
The Revenue is expected to grow by 3.61% on average over the next years.
EPS Next Y30.12%
EPS Next 2Y73.48%
EPS Next 3Y49.72%
EPS Next 5Y55.24%
Revenue Next Year2.25%
Revenue Next 2Y2.53%
Revenue Next 3Y2.48%
Revenue Next 5Y3.61%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CZR Yearly Revenue VS EstimatesCZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B
CZR Yearly EPS VS EstimatesCZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 -10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CZR. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 35.81, the valuation of CZR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CZR is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.81. CZR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 35.81
CZR Price Earnings VS Forward Price EarningsCZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

81.68% of the companies in the same industry are more expensive than CZR, based on the Enterprise Value to EBITDA ratio.
CZR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 111.27
EV/EBITDA 8.29
CZR Per share dataCZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

CZR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CZR's earnings are expected to grow with 49.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.48%
EPS Next 3Y49.72%

0

5. Dividend

5.1 Amount

No dividends for CZR!.
Industry RankSector Rank
Dividend Yield N/A

CAESARS ENTERTAINMENT INC

NASDAQ:CZR (8/22/2025, 8:01:25 PM)

After market: 26.77 +0.02 (+0.07%)

26.75

+1.75 (+7%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners111.4%
Inst Owner Change2.44%
Ins Owners0.93%
Ins Owner Change1.04%
Market Cap5.56B
Analysts79.13
Price Target43.16 (61.35%)
Short Float %11.36%
Short Ratio3.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-535.76%
Min EPS beat(2)-888.04%
Max EPS beat(2)-183.48%
EPS beat(4)1
Avg EPS beat(4)-266.78%
Min EPS beat(4)-888.04%
Max EPS beat(4)136.94%
EPS beat(8)2
Avg EPS beat(8)-394.68%
EPS beat(12)3
Avg EPS beat(12)-1114.77%
EPS beat(16)3
Avg EPS beat(16)-916.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-0.85%
Max Revenue beat(2)0.52%
Revenue beat(4)1
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-2.68%
Max Revenue beat(4)0.52%
Revenue beat(8)2
Avg Revenue beat(8)-1.52%
Revenue beat(12)4
Avg Revenue beat(12)-0.83%
Revenue beat(16)6
Avg Revenue beat(16)-0.82%
PT rev (1m)-2.84%
PT rev (3m)0.75%
EPS NQ rev (1m)-62.01%
EPS NQ rev (3m)-79.88%
EPS NY rev (1m)-688.51%
EPS NY rev (3m)-185.76%
Revenue NQ rev (1m)-0.85%
Revenue NQ rev (3m)-1.88%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 35.81
P/S 0.49
P/FCF 111.27
P/OCF 4.56
P/B 1.43
P/tB N/A
EV/EBITDA 8.29
EPS(TTM)-0.92
EYN/A
EPS(NY)0.75
Fwd EY2.79%
FCF(TTM)0.24
FCFY0.9%
OCF(TTM)5.87
OCFY21.95%
SpS54.69
BVpS18.73
TBVpS-51.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -5.01%
ROCE 7.29%
ROIC 5.76%
ROICexc 5.95%
ROICexgc 11.98%
OM 19.32%
PM (TTM) N/A
GM 48.39%
FCFM 0.44%
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
ROICexc(3y)5.94%
ROICexc(5y)4.47%
ROICexgc(3y)12.3%
ROICexgc(5y)9.19%
ROCE(3y)7.29%
ROCE(5y)5.47%
ROICexcg growth 3Y12.39%
ROICexcg growth 5Y-1.47%
ROICexc growth 3Y12.76%
ROICexc growth 5Y-4.07%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 6.43
Debt/FCF 503.2
Debt/EBITDA 6.98
Cap/Depr 84.12%
Cap/Sales 10.3%
Interest Coverage 8.08
Cash Conversion 34.02%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.81
Altman-Z 0.55
F-Score5
WACC5.6%
ROIC/WACC1.03
Cap/Depr(3y)93.85%
Cap/Depr(5y)77.92%
Cap/Sales(3y)10.59%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1850%
EPS Next Y30.12%
EPS Next 2Y73.48%
EPS Next 3Y49.72%
EPS Next 5Y55.24%
Revenue 1Y (TTM)-0.15%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%2.72%
Revenue Next Year2.25%
Revenue Next 2Y2.53%
Revenue Next 3Y2.48%
Revenue Next 5Y3.61%
EBIT growth 1Y-9.25%
EBIT growth 3Y10.07%
EBIT growth 5Y38.4%
EBIT Next Year68.18%
EBIT Next 3Y18.96%
EBIT Next 5Y16.36%
FCF growth 1Y-93.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.28%
OCF growth 3Y-3.11%
OCF growth 5Y28.03%